Tel Aviv Stock Exchange

ESMA recognises four new Third Country CCPs

Retrieved on: 
Tuesday, May 2, 2023

ESMA recognises four new Third Country CCPs

Key Points: 
  • ESMA recognises four new Third Country CCPs
    The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, has recognised four additional third country CCPs (TC-CCPs) under Article 25 of the European Market Infrastructure Regulation (EMIR), bringing the total number of TC-CCPs recognised by ESMA to 39.
  • The newly recognised TC-CCPs are:
    - Bursa Malaysia Derivatives Clearing Berhad (Malaysia);
    - Taiwan Futures Exchange Corporation (Taiwan);
    - Cámara de Riesgo Central de Contraparte de Colombia S.A. (Colombia); and
    - Tel-Aviv Stock Exchange Clearing House Ltd (Israel).
  • ESMA now has 25 cooperation arrangements for TC-CCP supervision with supervisory authorities from 20 third countries.
  • ESMA has updated its list of recognised third-country central counterparties (TC CCPs) accordingly.

Elbit Systems Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2022

Retrieved on: 
Monday, May 1, 2023

HAIFA, Israel, May 1, 2023 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced that on May 1, 2023, the Company filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 (the "2022 Annual Report") with the U.S. Securities and Exchange Commission, the Israel Securities Authority and the Tel Aviv Stock Exchange.

Key Points: 
  • HAIFA, Israel, May 1, 2023 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced that on May 1, 2023, the Company filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 (the "2022 Annual Report") with the U.S. Securities and Exchange Commission, the Israel Securities Authority and the Tel Aviv Stock Exchange.
  • The 2022 Annual Report can be viewed or downloaded at the Company's website at: www.elbitsystems.com .
  • In addition, the Company will provide shareholders with a hard copy of the 2022 Annual Report upon request, free of charge.
  • On the call, management will review and discuss the annual report and will be available to answer questions.

BioLineRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

Retrieved on: 
Tuesday, April 25, 2023

TEL AVIV, Israel, April 25, 2023 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

Key Points: 
  • TEL AVIV, Israel, April 25, 2023 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
  • BioLineRx is now in compliance with all applicable listing standards and its American Depository Shares (ADSs) will continue to be listed and traded on the NASDAQ Stock Market.
  • The Company was notified by Nasdaq on November 2, 2022, that its ADSs had failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
  • To regain compliance with the minimum bid price requirement, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days.

IceCure Medical Ordinary Shares to Trade Exclusively on Nasdaq: Company to Voluntarily Delist Shares from Trading on the Tel Aviv Stock Exchange

Retrieved on: 
Wednesday, April 19, 2023

In accordance with applicable Israeli law and the rules of the TASE, the last day the Ordinary Shares will trade on the TASE will be July 20, 2023 and the Ordinary Shares will be delisted from the TASE on July 24, 2023.

Key Points: 
  • In accordance with applicable Israeli law and the rules of the TASE, the last day the Ordinary Shares will trade on the TASE will be July 20, 2023 and the Ordinary Shares will be delisted from the TASE on July 24, 2023.
  • Until the last day of trading on the TASE, shareholders will be able to continue to buy and sell Ordinary Shares in the same manner as has been the case to date.
  • The delisting in Israel will not affect the Company's continued listing on Nasdaq in the United States and all Ordinary Shares now traded on the TASE may be transferred to Nasdaq.
  • "From an operational, developmental, and strategic perspective, Israel remains of vital importance to IceCure, while delisting from the TASE will reduce redundant listing costs.

The Tel-Aviv Stock Exchange (TASE) Continues to Advance ESG

Retrieved on: 
Monday, April 17, 2023

TEL AVIV, Israel, April 17, 2023 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) published today its first ESG questionnaire for the TASE-listed companies as a means to increasing their ESG involvement and allowing investors better access to ESG-related information, in line with international standards.

Key Points: 
  • The questionnaire was developed in collaboration with Good Vision, an ESG advisory firm, and is designed to assist companies that have not yet published an ESG report.
  • The questionnaire is based on an examination of similar questionnaires commonly used internationally, and was customized for the TASE-listed companies.
  • At the same time, the questionnaire and the links that will be submitted by the companies will be published on the dedicated ESG page of the TASE website.
  • To date, 40 ETFs and tracking funds on local and international ESG indices are traded on TASE, with an asset market cap of NIS 1.5 billion.

Money20/20 Europe Unveils Speaker Lineup

Retrieved on: 
Tuesday, April 4, 2023

Money20/20 , the world’s leading fintech show, unveils its agenda for the upcoming Europe show in Amsterdam, June 6-8th.

Key Points: 
  • Money20/20 , the world’s leading fintech show, unveils its agenda for the upcoming Europe show in Amsterdam, June 6-8th.
  • Over 300 speakers are expected to join Money20/20 Europe this year.
  • Hiroki Takeuchi, Co-founder and CEO of GoCardless, a global leader in direct bank payments, is one of Money20/20 Europe high profile speakers.
  • We see Money20/20 Europe as an impactful platform for helping us shape the green digital finance landscape globally.”

Molekule Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, March 30, 2023

Completed the acquisition of Molekule, Inc. on January 12, 2023 and changed the Company name to Molekule Group, Inc. and began trading under a new ticker symbol (NASDAQ: MKUL).

Key Points: 
  • Completed the acquisition of Molekule, Inc. on January 12, 2023 and changed the Company name to Molekule Group, Inc. and began trading under a new ticker symbol (NASDAQ: MKUL).
  • Net loss from operations for the fourth quarter of 2022 was $4.5 million.
  • Cash was $22 million as of December 31, 2022, compared to $19.6 million as of December 31, 2021.
  • Financial results and analyses are available on the Company’s investor relations website: https://investors.molekule.com/ .

THE TEL-AVIV STOCK EXCHANGE REPORTS THE RESULTS OF THE FINANCIAL STATEMENTS FOR THE FOURTH QUARTER AND FOR 2022

Retrieved on: 
Tuesday, March 28, 2023

TEL AVIV, Israel, March 28, 2023 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) today announced its financial results for the fourth quarter ended December 31, 2022 and for 2022.

Key Points: 
  • The net profit in 2022 increased by 12% and totaled NIS 50.8 million, compared to NIS 45.5 million in 2021.
  • The adjusted EBITDA in the fourth quarter of 2022 totaled NIS 32.1 million, compared to NIS 29.5 million in the corresponding quarter last year, an increase of 9% between the quarters.
  • Tax expenses, net in the fourth quarter of 2022 totaled NIS 5.2 million, compared to NIS 4.2 million in the corresponding quarter last year.
  • The adjusted profit in 2022 totaled NIS 51.4 million, compared to NIS 46.2 million in 2021, an increase of 11%.

Grace Breeding Reports 2022 Full-Year Financial Results

Retrieved on: 
Friday, March 24, 2023

REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) -- Grace Breeding Ltd. (the "Company" or "Grace Breeding") (TASE: GRAC), a forward-thinking AgClimateTech company developing biological-based products to improve crop yield and vigor today reported full-year financial results for the period ending December 31, 2022. 

Key Points: 
  • - Program developments throughout 2022, and, to date in 2023, bring Grace Breeding closer to offering crop solutions to farmers aligned with environmental responsibility and reversing climate change -
    REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) -- Grace Breeding Ltd. (the "Company" or "Grace Breeding") (TASE: GRAC), a forward-thinking AgClimateTech company developing biological-based products to improve crop yield and vigor today reported full-year financial results for the period ending December 31, 2022.
  • In September 2022, Grace Breeding announced results from field trials of NFT in Israel showing there was a yield increase of 18% in wheat production.
  • In October 2022, Grace Breeding announced results from field trials of WDS in Israel showing a yield increase of 17% in industrial tomato production.
  • In November 2022, Grace Breeding announced a strategic research and development collaboration with the prestigious University of Londrina (UEL), based in Paraná State, Brazil.

Phoenix Holdings Publishes 2022 Financial Statements and Reports Comprehensive Income of NIS 1.1 Billion with Dividend Distribution, Despite Capital Market Declines

Retrieved on: 
Thursday, March 23, 2023

As of December 31, 2022, equity capital totaled NIS 10.1 billion, following the NIS 160 million dividend distribution from 2022 first half income and a share buyback of NIS 56 million.

Key Points: 
  • As of December 31, 2022, equity capital totaled NIS 10.1 billion, following the NIS 160 million dividend distribution from 2022 first half income and a share buyback of NIS 56 million.
  • Profit from operations (before tax) amounted to NIS 1,796 million in 2022 and NIS 458 million in the fourth quarter of 2022.
  • The comprehensive income in 2022 and in the fourth quarter of 2022 amounted to NIS 611 million and NIS 115 million, respectively.
  • The decrease in comprehensive income before tax in 2022 and in the fourth quarter of 2022 amounted to NIS (958) million and NIS (202) million, respectively.